Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by ABBOTT
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
011679
PENTOTHAL
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
012775
ENDURONYL
ENDURONYL FORTE
New Drug Application
Approval
New combination
(S) Standard review drug
012828
TRAVASE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
013056
PENTHRANE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
013448
EUTONYL
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
016047
EUTRON
New Drug Application
Approval
New combination
(S) Standard review drug
016245
VERCYTE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
016814
NORISODRINE AEROTROL
New Drug Application
Approval
New manufacturer
(S) Standard review drug
016832
CYLERT
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
017013
SODIUM CHLORIDE
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017020
PANWARFIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017638
THYPINONE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
017703
CYLERT
New Drug Application
Approval
New formulation
(P) Priority review drug
017787
RADIONUCLIDE-LABELED (125 I) FIBRINOGEN (HUMAN) SENSOR
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
017895
JANIMINE
New Drug Application
Approval
New indication
(P) Priority review drug
018055
DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018203
LIPOSYN 10%
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
018297
LOPURIN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018462
RINGER'S IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018614
LIPOSYN 20%
New Drug Application
Approval
New formulation
(S) Standard review drug
018625
DISCASE
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018804
AMINOSYN 3.5% IN PLASTIC CONTAINER
AMINOSYN 3.5% M IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018875
AMINOSYN 3.5% IN PLASTIC CONTAINER
AMINOSYN 3.5% M IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018889
METRONIDAZOLE
New Drug Application
Approval
018923
DEXTROSE 38.5% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018954
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019005
BRETYLIUM TOSYLATE IN DEXTROSE 5%
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019057
HYTRIN
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
019080
PROSOM
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
019118
AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019119
AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019120
AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019185
OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
OXYTOCIN 5 USP UNITS IN DEXTROSE 5%
New Drug Application
Approval
New formulation
(S) Standard review drug
019218
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019399
TPN ELECTROLYTES IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019400
AMINOSYN-HBC 7% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019443
SODIUM BICARBONATE IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019482
DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019483
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019484
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019485
LACTATED RINGER'S IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019486
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019491
AMINOSYN II 3.5% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019493
AMINOSYN II 3.5% M IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019504
AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019505
AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019506
AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019564
AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER
AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019565
AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019712
AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER
AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019713
AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER
AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019714
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019784
IBU
New Drug Application
Approval
New formulation
(S) Standard review drug
019794
DEPAKOTE CP
New Drug Application
Approval
New formulation
(S) Standard review drug
020347
HYTRIN
New Drug Application
Approval
New formulation
(S) Standard review drug
020632
MERIDIA
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
020680
NORVIR
New Drug Application
Approval
New formulation
(P) Priority review drug
020782
DEPAKOTE ER
New Drug Application
Approval
New formulation
(S) Standard review drug
021203
TRICOR
New Drug Application
Approval
New formulation
(S) Standard review drug
050697
BIAXIN
New Drug Application
Approval
New indication
(S) Standard review drug
061802
TETRACYCLINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
062413
GENTAMICIN SULFATE
Abbreviated New Drug Application
Approval
062547
CEPHALOTHIN SODIUM
Abbreviated New Drug Application
Approval
062548
CEPHALOTHIN SODIUM
Abbreviated New Drug Application
Approval
062586
ERYTHROCIN
Abbreviated New Drug Application
Approval
063265
AMIKACIN SULFATE
Abbreviated New Drug Application
Approval
063266
AMIKACIN SULFATE
Abbreviated New Drug Application
Approval
064141
AMPHOTERICIN B
Abbreviated New Drug Application
Approval
070556
IBUPROFEN
Abbreviated New Drug Application
Approval
070636
FENTANYL CITRATE
Abbreviated New Drug Application
Approval
070637
FENTANYL CITRATE
Abbreviated New Drug Application
Approval
070656
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070657
DOPAMINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
070803
ENFLURANE
Abbreviated New Drug Application
Approval
070917
NALBUPHINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
071264
IBUPROFEN
Abbreviated New Drug Application
Approval
071555
NITROPRESS
Abbreviated New Drug Application
Approval
080001
CALCIUM GLUCEPTATE
Abbreviated New Drug Application
Approval
080385
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
080386
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
080387
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
080388
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
080389
MEPERIDINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
083130
AMMONIUM CHLORIDE
Abbreviated New Drug Application
Approval
083154
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE
Abbreviated New Drug Application
Approval
083159
CALCIUM GLUCEPTATE
Abbreviated New Drug Application
Approval
084075
PROPYLTHIOURACIL
Abbreviated New Drug Application
Approval
084160
PROMETHAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084166
PROMETHAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084222
PROMETHAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084223
PROMETHAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084411
CHLORPROMAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084412
CHLORPROMAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084413
CHLORPROMAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084414
CHLORPROMAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084415
CHLORPROMAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
084539
PROMETHAZINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
085447
A-POXIDE
Abbreviated New Drug Application
Approval
085513
A-POXIDE
Abbreviated New Drug Application
Approval
085517
A-POXIDE
Abbreviated New Drug Application
Approval
085518
A-POXIDE
Abbreviated New Drug Application
Approval
085667
VICODIN
Abbreviated New Drug Application
Approval
085928
A-HYDROCORT
Abbreviated New Drug Application
Approval
086333
VICOPRIN
Abbreviated New Drug Application
Approval
087364
CHLORTHALIDONE
Abbreviated New Drug Application
Approval
087384
CHLORTHALIDONE
Abbreviated New Drug Application
Approval
087980
LIDOCAINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
088572
PEDIATRIC LTA KIT
Abbreviated New Drug Application
Approval
089362
LIDOCAINE HYDROCHLORIDE
Abbreviated New Drug Application
Approval
089573
A-METHAPRED
Abbreviated New Drug Application
Approval
089574
A-METHAPRED
Abbreviated New Drug Application
Approval
089575
A-METHAPRED
Abbreviated New Drug Application
Approval
089576
A-METHAPRED
Abbreviated New Drug Application
Approval
089577
A-HYDROCORT
Abbreviated New Drug Application
Approval
089578
A-HYDROCORT
Abbreviated New Drug Application
Approval
089579
A-HYDROCORT
Abbreviated New Drug Application
Approval
089580
A-HYDROCORT
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval